Chapter/Section Purchase

1 Study Coverage
1.1 Genetic Disorders Drug Product Introduction
1.2 Market by Type
1.2.1 Global Genetic Disorders Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cystic Fibrosis (CF)
1.2.3 Duchenne Muscular Dystrophy (DMD)
1.2.4 Lysosomal Storage Disease (LSD)
1.2.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
1.3 Market by Application
1.3.1 Global Genetic Disorders Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Genetic Disorders Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Genetic Disorders Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Genetic Disorders Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Genetic Disorders Drug Sales by Region
2.4.1 Global Genetic Disorders Drug Sales by Region (2017-2022)
2.4.2 Global Sales Genetic Disorders Drug by Region (2023-2028)
2.5 Global Genetic Disorders Drug Revenue by Region
2.5.1 Global Genetic Disorders Drug Revenue by Region (2017-2022)
2.5.2 Global Genetic Disorders Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Genetic Disorders Drug Sales by Manufacturers
3.1.1 Global Top Genetic Disorders Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Genetic Disorders Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genetic Disorders Drug in 2021
3.2 Global Genetic Disorders Drug Revenue by Manufacturers
3.2.1 Global Genetic Disorders Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Genetic Disorders Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Genetic Disorders Drug Revenue in 2021
3.3 Global Genetic Disorders Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Genetic Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Genetic Disorders Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Genetic Disorders Drug Sales by Type
4.1.1 Global Genetic Disorders Drug Historical Sales by Type (2017-2022)
4.1.2 Global Genetic Disorders Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Genetic Disorders Drug Sales Market Share by Type (2017-2028)
4.2 Global Genetic Disorders Drug Revenue by Type
4.2.1 Global Genetic Disorders Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Genetic Disorders Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
4.3 Global Genetic Disorders Drug Price by Type
4.3.1 Global Genetic Disorders Drug Price by Type (2017-2022)
4.3.2 Global Genetic Disorders Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Genetic Disorders Drug Sales by Application
5.1.1 Global Genetic Disorders Drug Historical Sales by Application (2017-2022)
5.1.2 Global Genetic Disorders Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Genetic Disorders Drug Sales Market Share by Application (2017-2028)
5.2 Global Genetic Disorders Drug Revenue by Application
5.2.1 Global Genetic Disorders Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Genetic Disorders Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
5.3 Global Genetic Disorders Drug Price by Application
5.3.1 Global Genetic Disorders Drug Price by Application (2017-2022)
5.3.2 Global Genetic Disorders Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Genetic Disorders Drug Market Size by Type
6.1.1 North America Genetic Disorders Drug Sales by Type (2017-2028)
6.1.2 North America Genetic Disorders Drug Revenue by Type (2017-2028)
6.2 North America Genetic Disorders Drug Market Size by Application
6.2.1 North America Genetic Disorders Drug Sales by Application (2017-2028)
6.2.2 North America Genetic Disorders Drug Revenue by Application (2017-2028)
6.3 North America Genetic Disorders Drug Market Size by Country
6.3.1 North America Genetic Disorders Drug Sales by Country (2017-2028)
6.3.2 North America Genetic Disorders Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Genetic Disorders Drug Market Size by Type
7.1.1 Europe Genetic Disorders Drug Sales by Type (2017-2028)
7.1.2 Europe Genetic Disorders Drug Revenue by Type (2017-2028)
7.2 Europe Genetic Disorders Drug Market Size by Application
7.2.1 Europe Genetic Disorders Drug Sales by Application (2017-2028)
7.2.2 Europe Genetic Disorders Drug Revenue by Application (2017-2028)
7.3 Europe Genetic Disorders Drug Market Size by Country
7.3.1 Europe Genetic Disorders Drug Sales by Country (2017-2028)
7.3.2 Europe Genetic Disorders Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Genetic Disorders Drug Market Size by Type
8.1.1 Asia Pacific Genetic Disorders Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Genetic Disorders Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Genetic Disorders Drug Market Size by Application
8.2.1 Asia Pacific Genetic Disorders Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Genetic Disorders Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Genetic Disorders Drug Market Size by Region
8.3.1 Asia Pacific Genetic Disorders Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Genetic Disorders Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Genetic Disorders Drug Market Size by Type
9.1.1 Latin America Genetic Disorders Drug Sales by Type (2017-2028)
9.1.2 Latin America Genetic Disorders Drug Revenue by Type (2017-2028)
9.2 Latin America Genetic Disorders Drug Market Size by Application
9.2.1 Latin America Genetic Disorders Drug Sales by Application (2017-2028)
9.2.2 Latin America Genetic Disorders Drug Revenue by Application (2017-2028)
9.3 Latin America Genetic Disorders Drug Market Size by Country
9.3.1 Latin America Genetic Disorders Drug Sales by Country (2017-2028)
9.3.2 Latin America Genetic Disorders Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Genetic Disorders Drug Market Size by Type
10.1.1 Middle East and Africa Genetic Disorders Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Genetic Disorders Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Genetic Disorders Drug Market Size by Application
10.2.1 Middle East and Africa Genetic Disorders Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Genetic Disorders Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Genetic Disorders Drug Market Size by Country
10.3.1 Middle East and Africa Genetic Disorders Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Genetic Disorders Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Vertex
11.2.1 Vertex Corporation Information
11.2.2 Vertex Overview
11.2.3 Vertex Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vertex Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vertex Recent Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Takeda Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Recent Developments
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Overview
11.4.3 Amgen Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amgen Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
11.5 GW Pharmaceuticals
11.5.1 GW Pharmaceuticals Corporation Information
11.5.2 GW Pharmaceuticals Overview
11.5.3 GW Pharmaceuticals Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GW Pharmaceuticals Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GW Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 BioMarin
11.7.1 BioMarin Corporation Information
11.7.2 BioMarin Overview
11.7.3 BioMarin Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BioMarin Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BioMarin Recent Developments
11.8 Sarepta
11.8.1 Sarepta Corporation Information
11.8.2 Sarepta Overview
11.8.3 Sarepta Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sarepta Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sarepta Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Genetic Disorders Drug Industry Chain Analysis
12.2 Genetic Disorders Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genetic Disorders Drug Production Mode & Process
12.4 Genetic Disorders Drug Sales and Marketing
12.4.1 Genetic Disorders Drug Sales Channels
12.4.2 Genetic Disorders Drug Distributors
12.5 Genetic Disorders Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Genetic Disorders Drug Industry Trends
13.2 Genetic Disorders Drug Market Drivers
13.3 Genetic Disorders Drug Market Challenges
13.4 Genetic Disorders Drug Market Restraints
14 Key Findings in The Global Genetic Disorders Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer